SCHEMBL15070852

SCHEMBL15070852

CC(C)c1cnc2c(c1)CCCC2=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.36
MAOA P21397 2/20 0.32
MAOB P27338 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
PRKCI P41743 1/20 0.32
MAPK1 P28482 1/20 0.32
CYP2A6 P11509 1/20 0.32
PLK1 P53350 1/20 0.31
CSNK2A1 P68400 1/20 0.31
PLK3 Q9H4B4 1/20 0.31
PDK1 Q15118 1/20 0.31
PDK2 Q15119 1/20 0.31
PDK3 Q15120 1/20 0.31
PDK4 Q16654 1/20 0.31
ALDH1A1 P00352 2/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15070844 0.89 CYP11B1 (0.31)
SCHEMBL883070 0.79 KMT2A (0.39) MAOAMAOBMEN1KMT2ANPSR1
SCHEMBL15871379 0.77 ADRA2A (0.40) KDM4EMAPK1ALDH1A1
SCHEMBL10271348 0.75 MAOA (0.37) KDM4EMAOAMAOBMEN1KMT2A
SCHEMBL29561118 0.75 MAOA (0.36) KDM4EMAOAMAOBMEN1KMT2A
SCHEMBL883082 0.75 MAOA (0.36) KDM4EMAOAMAOBMEN1KMT2A
SCHEMBL10271350 0.75 MAOA (0.49) KDM4EMAOAMAOBMEN1KMT2A
SCHEMBL12696394 0.75 NOS3 (0.37) MAOAMAOBMEN1KMT2ANPSR1
SCHEMBL10286601 0.75 CYP11B2 (0.37) MAOAMAOBPRKCI
SCHEMBL4761258 0.75 EGFR (0.38) KDM4EMAOAMAOBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130165472-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 US disclosed
US-20130165483-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 US disclosed
US-20130165464-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165472-A1 HETEROARYLS AND USES THEREOF PIK3R4, VPS4B, PIK3C2A KDM4E 1283/4885MAOA 3168/4885MAOB 2886/4885
US-20130165483-A1 HETEROARYLS AND USES THEREOF PIK3R5, PIK3R4, PIK3C2B KDM4E 1720/4885MAOA 4628/4885MAOB 2608/4885
US-20130165464-A1 HETEROARYLS AND USES THEREOF PIK3C2B, PI4KB, PIK3R4 KDM4E 1614/4885MAOA 4378/4885MAOB 1425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.